PlexusDx offers the Precision Peptide Genetic Test (available as a $99 add-on after your first month of treatment) to map 14 metabolic pathways, 49 peptides, and 150+ genetic insights, including variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that influence your individual response to tirzepatide and other GLP-1 compounds
In this metabolomic profiling study, 13 long-chain acylcarnitines were analyzed which included 6 saturated (C14, C16, C18, C14OH, C16OH, and C18OH), 5 monounsaturated (C14:1, C16:1, C18:1, C16:1OH, and C18:1OH), and 2 polyunsaturated (C14:2 and C18:2) acylcarnitines
By the end of 2025, WEGOVY was available in 52 countries worldwide, nearly doubling its global footprint, with additional launches planned for 2026, subject to regulatory approvals
This personalization prevents months of ineffective therapy and unnecessary medication switches